Kerendia Approved to Reduce CKD Progression, CV Risk in Patients With Diabetic Kidney Disease
The approval was based on data from the phase 3 FIDELIO-DKD trial.
The approval was based on data from the phase 3 FIDELIO-DKD trial.
A study of patients who initiated dialysis in the Southeast United States found that those receiving care at for-profit facilities were 16% less likely to receive a kidney transplant referral than patients at non-profit facilities.
In a study comparing the effect of 9 oral nonsteroidal anti-inflammatory drugs on kidney function, ibuprofen conferred the lowest risk for incident eGFR less than 60 mL/min/1.73 m2 and an eGFR decline of 30% or greater.